About HighTide Therapeutics
HighTide Therapeutics is a company based in Rockville (United States) founded in 2011.. HighTide Therapeutics has raised $107 million across 2 funding rounds from investors including CITIC, TCM Health Care and Yuexiu Capital. The company has 70 employees as of December 31, 2024. HighTide Therapeutics operates in a competitive market with competitors including NGM Biopharmaceuticals, Ironwood Pharma, Nimbus Therapeutics, Adocia and Altimmune, among others.
- Headquarter Rockville, United States
- Employees 70 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hightide Therapeutics Inc
-
Annual Revenue
$0 (USD)0as on Dec 31, 2024
-
Net Profit
$-53.3 M (USD)60.12as on Dec 31, 2024
-
EBITDA
$-61.27 M (USD)-4.72as on Dec 31, 2024
-
Total Equity Funding
$107 M (USD)
in 2 rounds
-
Latest Funding Round
$107 M (USD), Series C
Jan 05, 2023
-
Investors
CITIC
& 5 more
-
Employee Count
70
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of HighTide Therapeutics
HighTide Therapeutics is a publicly listed company on the HKEX with ticker symbol 2511 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of HighTide Therapeutics
HighTide Therapeutics has successfully raised a total of $107M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $107 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $107.0M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Series C - HighTide Therapeutics | Valuation | Tcmhealthcare | |
| Dec, 2020 | Amount | Series B - HighTide Therapeutics | Valuation | CITIC Securities , Cowin Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HighTide Therapeutics
HighTide Therapeutics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include CITIC, TCM Health Care and Yuexiu Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Yuexiu Capital is engaged in financial services and asset management.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
TCM Health Care is focused on Traditional Chinese Medicine therapies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HighTide Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - HighTide Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hightide Therapeutics Comparisons
Competitors of HighTide Therapeutics
HighTide Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NGM Biopharmaceuticals, Ironwood Pharma, Nimbus Therapeutics, Adocia and Altimmune, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biologics are developed for cardio-metabolic and liver diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hightide Therapeutics
Frequently Asked Questions about HighTide Therapeutics
When was HighTide Therapeutics founded?
HighTide Therapeutics was founded in 2011 and raised its 1st funding round 9 years after it was founded.
Where is HighTide Therapeutics located?
HighTide Therapeutics is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Is HighTide Therapeutics a funded company?
HighTide Therapeutics is a funded company, having raised a total of $107M across 2 funding rounds to date.
How many employees does HighTide Therapeutics have?
As of Dec 31, 2024, the latest employee count at HighTide Therapeutics is 70.
What does HighTide Therapeutics do?
Developer of small molecule based therapeutics for the treatment of liver, gastrointestinal, and metabolic disorders. The companys lead product candidate HTD-1801 used for the treatment of primary sclerosing cholangitis, NAFLDNASH, and hypercholesterolemia. Other products of the company include HTD4010 used for the treatment of acute pancreatitis, HTD1804 for obesiry, HTD1805 for metabolic disease, and HTD2802 for IBD.
Who are the top competitors of HighTide Therapeutics?
HighTide Therapeutics's top competitors include Ironwood Pharma, Nimbus Therapeutics and Adocia.
Is HighTide Therapeutics publicly traded?
Yes, HighTide Therapeutics is publicly traded on HKEX under the ticker symbol 2511.
Who are HighTide Therapeutics's investors?
HighTide Therapeutics has 6 investors. Key investors include CITIC, TCM Health Care, Yuexiu Capital, Hongde Fund Management, and Cowin Capital.
What is HighTide Therapeutics's ticker symbol?
The ticker symbol of HighTide Therapeutics is 2511 on HKEX.